v3.26.1
SCHEDULE OF PREFERRED STOCK ISSUED AND OUTSTANDING (Details) (Parenthetical) - USD ($)
 12 Months Ended
Apr. 15, 2026
Jan. 23, 2026
Jan. 01, 2026
Dec. 19, 2025
 [1]
Nov. 13, 2025
 [1]
Oct. 30, 2025
Jun. 27, 2024
Apr. 22, 2024
Apr. 15, 2024
Jan. 17, 2024
Dec. 31, 2025
Dec. 31, 2024
Oct. 25, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Accrued payroll                     $ 941,890 $ 214,780    
Accured prior year                     $ 214,780      
Common stock, shares issued                     108,147,731 86,782,908    
Common stock, par value                     $ 0.001 $ 0.001 $ 0.092  
Weighted average remaining contractual term, Ending balance                     4 years 7 months 6 days      
Weighted Average Exercise Price                     $ 0.13 $ 0.22   $ 0.29
Shares issued to consultants - 2021 Plan                     $ 121,062 $ 199,682    
Market price                     $ 0.0758      
Private Placement [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Shares issued to consultants - 2021 Plan, shares [2]       1,170,000 15,444,001 226,937 212,766 194,553 173,077 333,333        
Shares issued to consultants - 2021 Plan [2]       $ 35,498 $ 389,872 $ 13,616 $ 20,000 $ 25,000 $ 18,000 $ 45,000        
Market price       $ 0.030 [2] $ 0.025 [2] $ 0.060 [2] $ 0.094 [2] $ 0.128 [2] $ 0.104 [2] $ 0.135 [2] $ 0.0256      
Warrant [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants Outstanding, Number of Warrants                     16,675,364      
Weighted average remaining contractual term, Ending balance                     4 years 7 months 6 days      
Subsequent Event [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Common stock, shares issued   4,366,667                        
Common stock, par value   $ 0.06                        
Broker commission   $ 20,960                        
Subsequent Event [Member] | Common Stock [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Shares issued to consultants - 2021 Plan, shares   349,333                        
Shares issued to consultants - 2021 Plan   $ 241,040                        
Market price   $ 0.051                        
Subsequent Event [Member] | Private Placement [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Private placement offering   $ 262,000                        
Market price     $ 0.0309                      
Subsequent Event [Member] | Warrant [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants Outstanding, Number of Warrants 21,042,031   16,675,364                      
Weighted average remaining contractual term, Ending balance 4 years 7 months 6 days   4 years 7 months 6 days                      
Weighted Average Exercise Price $ 0.12   $ 0.13                      
Subsequent Event [Member] | Warrant [Member] | Private Placement [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants Outstanding, Number of Warrants [3],[4]   4,366,667                        
Weighted average remaining contractual term, Ending balance [3],[4]   5 years                        
Weighted Average Exercise Price [3],[4]   $ 0.12                        
[1] See further Note 11
[2] The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.
[3] Around January 23, 2026, the Company issued 4,366,667 shares of Common Stock at a price of $0.06 per share, as well as 4,366,667 (100% coverage) 5-year warrants exercisable to Common Stock at $0.12 per share, as part of a $262,000 private placement offering. A commission of $20,960 (8%) was awarded to the (Member FINRA / SIPC) broker, along with 349,333 (8%) shares of Common Stock, was directly integrated into the purchase. Generating $241,040 ($0.051/share) in net cash received.
[4] The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.